Showing results (1401-1410 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|October 9, 2014
Benefits and risks of using smart pumps to reduce medication error rates: a systematic reviewKumiko Ohashi, Olivia Dalleur, Patricia C Dykes, et al.
Drug Safety|October 30, 2014
Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trialsMark I Avigan, Einar S Bjornsson, Markku Pasanen, et al.
Drug Safety|October 30, 2014
Liver safety assessment in special populations (hepatitis B, C, and oncology trials)Gerd A Kullak-Ublick, Michael Merz, Louis Griffel, et al.
Drug Safety|October 19, 2017
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsTerufumi Kato, Takashi Seto, Makoto Nishio, et al.
Drug Safety|February 7, 2018
Drug-Induced Ototoxicity: Diagnosis and MonitoringKathleen C M Campbell, Colleen G Le Prell
Drug Safety|February 8, 2018
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic ReviewMartin Braddock, Nicola A Hanania, Amir Sharafkhaneh, et al.
Drug Safety|December 9, 2017
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled TrialsDao Thai-Cuarto, Christopher F O'Brien, Roland Jimenez, et al.
Drug Safety|January 11, 2018
A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical TrialsMargaret Coates, Marina Spanos, Pooja Parmar, et al.
Drug Safety|December 28, 2017
Safety of Human Papillomavirus Vaccines: An Updated ReviewAnastasia Phillips, Cyra Patel, Alexis Pillsbury, et al.
Drug Safety|March 2, 2018
Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial ExperienceJohn F Marcinak, Melvin S Munsaka, Paul B Watkins, et al.
Pageof 311